To further explore the impacts of the expression levels of LOC541471, STK25, SOD1, and GDAP1 on the RFS of AML patients, we performed Kaplan–Meier survival analysis in the validation cohort, and found that the expression levels of these four genes had no significant correlation with RFS (p > 0.05, Figure S2). The gene discussed is STK25; the disease is acute myeloid leukemia.